Francesco Angelini

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

A simple apparatus for studying the release of neurotransmitters from synaptosomes

Maurizio Raiteri, Francesco Angelini, Giulio Levi · European Journal of Pharmacology · 1974 · 458 citations

Simple Apparatus, Neuromodulation, Neurophysiology +13

d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes

Maurizio Raiteri, Alberto Bertollini, Francesco Angelini et al. · European Journal of Pharmacology · 1975 · 146 citations

Psychoactive Drug, Medicine, Biogenic Amines +8

Localization of FMRFamide-Like Immunoreactivity in the Brain of the Viviparous Skink <i>(Chalcides chalcides)</i>

Biagio D’Aniello, Maria Fiorentin, Claudia Pinelli et al. · Brain Behavior and Evolution · 2001 · 87 citations

Brain Development, Dermatology, Fmrfamide-ir Innervation +20

Human cardiosphere-seeded gelatin and collagen scaffolds as cardiogenic engineered bioconstructs

Isotta Chimenti, Giuseppe Rizzitelli, Roberto Gaetani et al. · Biomaterials · 2011 · 69 citations

Tissue Engineering, Regenerative Medicine, Vascular Tissue Engineering +13